Suggestions
Yingjie (Angie) Shen
00001001 00001001 00000110 00000110
Yingjie (Angie) Shen is a neuroscientist and entrepreneur who co-founded PEARL Neuroscience, where she serves as the Chief Scientific Officer. Her research focuses on understanding the molecular and cellular mechanisms of central nervous system (CNS) injuries and degenerative diseases.1
Dr. Shen's work involves studying:
- Molecular and cellular mechanisms of CNS injuries
- Neurodegenerative diseases
- Proteolytic metabolism of APP (amyloid precursor protein)
- Alzheimer's disease-related pathogenesis
Her research has contributed to insights on how neuronal receptor binding to APP in the brain regulates its proteolytic metabolism, which is relevant to Alzheimer's disease pathology.2
As an active researcher and thought leader in her field, Dr. Shen engages with the scientific community through various channels. She has been featured on podcasts discussing topics related to aging and neuroscience.3 Her LinkedIn profile (username: yingjieashen) serves as a platform for her to share updates on her work and connect with other professionals in the field.
At PEARL Neuroscience, Dr. Shen likely applies her expertise in neurodegenerative diseases and CNS injuries to develop innovative approaches for diagnosing and treating neurological conditions. Her role as Chief Scientific Officer suggests she plays a key part in guiding the company's research and development strategies.